Effect of protease inhibitors combined with standard antiretroviral therapy on linear growth and weight gain in human immunodeficiency virus type 1-infected children

被引:24
作者
Dreimane, D
Nielsen, K
Deveikis, A
Bryson, YJ
Geffner, ME
机构
[1] Univ Calif Los Angeles, Mattel Childrens Hosp, Dept Pediat, Los Angeles, CA USA
[2] Mem Miller Childrens Hosp, Long Beach, CA USA
关键词
human immunodeficiency virus type 1 infection in children; protease inhibitors; linear growth; weight gain;
D O I
10.1097/00006454-200103000-00020
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Children with HIV-1 infection and poor growth have a significant increase in the risk of death. We studied the effects of protease inhibitors on the height and weight of 27 HIV-1-infected children and found that in our small pilot study, protease inhibitor therapy had a positive effect on the heights of HIV-1-infected children. Accelerated height velocity was sustained for at least 18 to 20 months.
引用
收藏
页码:315 / 316
页数:2
相关论文
共 10 条
[1]   Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease [J].
Autran, B ;
Carcelain, G ;
Li, TS ;
Blanc, C ;
Mathez, D ;
Tubiana, R ;
Katlama, C ;
Debre, P ;
Leibowitch, J .
SCIENCE, 1997, 277 (5322) :112-116
[2]   Growth failure as a prognostic indicator of mortality in pediatric HIV infection [J].
Berhane, R ;
Bagenda, D ;
Marum, L ;
Aceng, E ;
Ndugwa, C ;
Bosch, RJ ;
Olness, K .
PEDIATRICS, 1997, 100 (01) :art. no.-e7
[3]   Pediatric AIDS prognosis using somatic growth velocity [J].
Carey, VJ ;
Yong, FH ;
Frenkel, LM ;
McKinney, RE .
AIDS, 1998, 12 (11) :1361-1369
[4]   Growth hormone exerts potent anabolic effects in an adolescent with human immunodeficiency virus wasting [J].
Dreimane, D ;
Gallagher, K ;
Nielsen, K ;
Krogstad, P ;
Stiehm, ER ;
Bryson, YJ ;
Geffner, ME .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1999, 18 (02) :167-169
[5]  
Hardin DS, 1999, PEDIATR RES, V45, p90A, DOI 10.1203/00006450-199904020-00538
[6]   Clinical, virologic and immunologic responses of children with advanced human immunodeficiency virus type 1 disease treated with protease inhibitors [J].
Melvin, AJ ;
Mohan, KM ;
Arcuino, LAM ;
Edelstein, RE ;
Frenkel, LM .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (10) :968-974
[7]   GROWTH AND BODY-COMPOSITION IN CHILDREN INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS-1 [J].
MILLER, TL ;
EVANS, SJ ;
ORAV, EJ ;
MORRIS, V ;
MCINTOSH, K ;
WINTER, HS .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1993, 57 (04) :588-592
[8]  
Nadal D, 1998, AIDS, V12, P2356
[9]   Impaired early growth of infants perinatally infected with human immunodeficiency virus: Correlation with viral load [J].
Pollack, H ;
Glasberg, H ;
Lee, E ;
Nirenberg, A ;
David, R ;
Krasinski, K ;
Borkowsky, W ;
Oberfield, S .
JOURNAL OF PEDIATRICS, 1997, 130 (06) :915-922
[10]   The effect of protease inhibitors on weight and body composition in HIV-infected patients [J].
Silva, M ;
Skolnik, PR ;
Gorbach, SL ;
Spiegelman, D ;
Wilson, IB ;
Fernández-DiFranco, MG ;
Knox, TA .
AIDS, 1998, 12 (13) :1645-1651